Related Experiment Video
Updated: May 24, 2026
06:42
A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
Gene delivery technologies for cardiac applications.
M G Katz1, A S Fargnoli, L A Pritchette
1Department of Thoracic and Cardiovascular Surgery, Sanger Heart and Vascular Institute, Cannon Research Center, Carolinas HealthCare System, Charlotte, NC, USA.
Gene Therapy
|March 16, 2012
Summary
Gene therapy offers new hope for ischemic heart disease (IHD) and heart failure (HF) by improving genetic transfer methods. Research focuses on targeted delivery for IHD and global cardiomyocyte transduction for HF, enhancing treatment efficacy.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Gene Therapy
Background:
- Ischemic heart disease (IHD) and heart failure (HF) are leading causes of death.
- Advances in molecular pathology and vector technology enable gene-based therapies for cardiac conditions.
- Effective gene transfer is crucial for therapeutic success.
Purpose of the Study:
- To review gene-transfer strategies for coronary artery disease and heart failure.
- To discuss advancements in direct and transvascular gene delivery methods.
- To evaluate the success of vector-mediated cardiac gene delivery.
Main Methods:
- Review of current gene therapy research in models of IHD and HF.
- Analysis of localized gene delivery via catheters and stents for IHD.
- Examination of global cardiomyocyte transduction for HF treatment.
Main Results:
- Gene therapy strategies are evolving for IHD and HF.
- Localized delivery targets angiogenesis and endothelial function in IHD.
- Global transduction aims to inhibit apoptosis, reduce remodeling, and increase contractility in HF.
Conclusions:
- Gene therapy holds significant potential for treating IHD and HF.
- Optimizing gene transfer efficiency is key to clinical success.
- Targeted approaches differ between IHD and HF, reflecting disease-specific needs.
